Use of antiosteoporotic medication in the Danish ROSE population-based screening study

Høiberg, Mikkel; Rubin, Katrine Hass; Holmberg, Teresa; Rothmann, Mette Juel; Möller, Sören; Gram, Jeppe; Bech, Mickael; Brixen, Kim; Hermann, Anne Pernille

doi:10.1007/s00198-019-04934-7

Cited by 2 publications

(2 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Overall, only 45% of patients with a diagnosis of osteoporosis and 42% of patients deemed at high risk of a hip or a major osteoporosis-related fracture were prescribed an osteoporosis medication. Adherence and persistence to anti-osteoporotic medications have also been shown to be low in other population-based primary prevention studies ( Høiberg et al, 2019 ). Despite the number of available drugs to treat osteoporosis, limited acceptance in pharmaceutical treatments may result from fear of rare side effects and concern for long-term efficacy ( Khosla & Hofbauer, 2017 ).…”

Section: Discussionmentioning

confidence: 99%

Use of Clinical Practice Guidelines and Quality Metrics to Assess Primary Care Management of Osteoporosis

Camp,

Hartos,

Atanda

2023

Gerontology and Geriatric Medicine

View full text Add to dashboard Cite

Background: Clinical practice guidelines and quality measures provide recommendations for physicians addressing osteoporosis management. This study explored the alignment of osteoporosis clinical practice in a primary care geriatric clinic with recommended guidelines. Methods: This retrospective chart review included 388 patients 65 or older from a primary care geriatric clinic diagnosed with osteopenia or osteoporosis, with or without a fragility fracture. Data included history of falls and use of DXA scans, FRAX® fracture risk assessment tool, osteoporosis medication, and fall risk mitigation plans. Results: For age-related primary fracture prevention, 68% of women and 87% of men had documented DXA scans, and 45% of patients diagnosed with osteoporosis and 42% determined at high risk were prescribed osteoporosis medication. For secondary fracture prevention, 72% of women aged 67 to 85 had DXA scans and 21% were prescribed osteoporosis medication. Only 10% of patients with a history of falls had documented fall risk management plans. Conclusion: Although showing higher rates of primary and secondary prevention outcomes than did research results from general primary care, gaps were identified for high fracture risk patients and fall risk management documentation. Medical record review may not provide sufficient data to capture factors influencing decision-making for fracture prevention.

show abstract

Section: Discussionmentioning

confidence: 99%

Use of Clinical Practice Guidelines and Quality Metrics to Assess Primary Care Management of Osteoporosis

Camp,

Hartos,

Atanda

2023

Gerontology and Geriatric Medicine

View full text Add to dashboard Cite

show abstract

“…The latter decision was underpinned by the conclusion that there was no randomised controlled trial assessing the clinical and cost-effectiveness of any current approach to screening for osteoporosis. The SCOOP study has now addressed this, and recently another study of screening using the FRAX tool has been published from Denmark [34][35][36]. While no formal cost-effectiveness analysis has yet been published from the latter study, the FRAX approach in both studies reduces the use of bone mineral density measurements, thus reducing this contribution to screening costs.…”

Section: Discussionmentioning

confidence: 99%

Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study

et al. 2020

View full text Add to dashboard Cite

Community-based screening and treatment of women age 70-85 years at high fracture risk reduced fractures; moreover, the screening programme was cost-saving. The results support a case for a screening programme of fracture risk in older women in the UK.Purpose-The SCOOP (screening for prevention of fractures in older women) randomised controlled trial investigated whether community-based screening could reduce fractures in women age 70-85 years. The objective of this study was to estimate the long-term cost-effectiveness of screening for fracture risk in a UK primary care setting compared with usual management, based on the SCOOP study.

show abstract

Use of antiosteoporotic medication in the Danish ROSE population-based screening study

Cited by 2 publications

References 37 publications

Use of Clinical Practice Guidelines and Quality Metrics to Assess Primary Care Management of Osteoporosis

Use of Clinical Practice Guidelines and Quality Metrics to Assess Primary Care Management of Osteoporosis

Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study

Contact Info

Product

Resources

About